Breaking News Instant updates and real-time market news.

IVITF

Invictus MD Strategies

$0.00 /

+ (+0.00%)

09:09
09/11/19
09/11
09:09
09/11/19
09:09

Invictus MD Strategies says AB Laboratories receives amended license

INVICTUS MD STRATEGIES announced that AB Laboratories, a company which is a 50% owned subsidiary of Invictus, has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario. As previously announced on June 26, 2019, AB Labs' facility contains ten identical cultivation rooms capable of producing over 65 crops annually on a tightly controlled weekly production schedule. Five rooms have been propagated since receiving the amended license on August 30, 2019. The initial harvest is scheduled for November 1, 2019. The remaining rooms are expected to be propagated at a rate of one room per week over the next five weeks to ensure a reliable continuous production of cannabis for the recreational and medical markets.

TODAY'S FREE FLY STORIES

Hot Stocks
Amicus announces 2020 key strategic priorities » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Achieve $250 million to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Hot Stocks
Phoenix New Media enters into share repurchase agreement with Run Liang » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FENG

Phoenix New Media

$1.50 /

+ (+0.00%)

Phoenix New Media…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FENG Phoenix New Media
$1.50 /

+ (+0.00%)

Hot Stocks
Amicus sees cash position funding operations through to profitability » 07:23
08/10/20
08/10
07:23
08/10/20
07:23
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Earnings
Amicus sees 2020 Galafold revenue $250M-$260M, consensus $254.82M  07:22
08/10/20
08/10
07:22
08/10/20
07:22
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

 
ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Initiation
GoHealth initiated with an Outperform at Evercore ISI » 07:22
08/10/20
08/10
07:22
08/10/20
07:22
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

07:21 Today Truist
GoHealth initiated with a Buy at Truist
06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Amicus reports Q2 EPS (20c), consensus (26c) » 07:22
08/10/20
08/10
07:22
08/10/20
07:22
FOLD

Amicus

$15.39 /

+0.03 (+0.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

FOLD Amicus
$15.39 /

+0.03 (+0.20%)

06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
06/08/20 JPMorgan
Amicus weakness 'overdone' following Sanofi update, says JPMorgan
FOLD Amicus
$15.39 /

+0.03 (+0.20%)

Initiation
GoHealth initiated with a Buy at Truist » 07:21
08/10/20
08/10
07:21
08/10/20
07:21
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Hot Stocks
TG Therapeutics announces key objectives for 2020, early 2021 » 07:21
08/10/20
08/10
07:21
08/10/20
07:21
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Report topline results…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Hot Stocks
TG Therapeutics expects cash to fund operations through the end of 2021 » 07:20
08/10/20
08/10
07:20
08/10/20
07:20
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Earnings
TG Therapeutics reports Q2 EPS (47c), consensus (34c) » 07:20
08/10/20
08/10
07:20
08/10/20
07:20
TGTX

TG Therapeutics

$20.96 /

+0.15 (+0.72%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

06/12/20 H.C. Wainwright
TG Therapeutics data presentations at EHA 'compelling,' says H.C. Wainwright
05/18/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/17/20 B. Riley FBR
TG Therapeutics price target raised to $37 from $29 at B. Riley FBR
05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

  • 15
    May
TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

TGTX TG Therapeutics
$20.96 /

+0.15 (+0.72%)

Recommendations
Nvidia price target raised to $520 from $460 at BofA » 07:19
08/10/20
08/10
07:19
08/10/20
07:19
NVDA

Nvidia

$448.07 /

-5.355 (-1.18%)

BofA analyst Vivek Arya…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

08/03/20 Morgan Stanley
Synergies unclear if Nvidia buys controlling ARM interest, says Morgan Stanley
07/24/20 Raymond James
Intel 7nm delay positive for AMD, TSMC, Nvidia, says Raymond James
07/24/20 BMO Capital
Intel price target lowered to $50 from $55 at BMO Capital
07/14/20 Cowen
Nvidia price target raised to $475 from $410 at Cowen
NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

NVDA Nvidia
$448.07 /

-5.355 (-1.18%)

Initiation
nCino initiated with a Buy at Truist » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
NCNO

nCino

$75.71 /

+0.21 (+0.28%)

Truist analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$75.71 /

+0.21 (+0.28%)

06:59 Today Raymond James
nCino initiated with a Market Perform at Raymond James
06:57 Today KeyBanc
KeyBanc bullish on nCino, initiates with an Overweight
06:19 Today BofA
nCino initiated with a Buy at BofA
06:14 Today Piper Sandler
nCino initiated with an Overweight at Piper Sandler
  • 14
    Jul
NCNO nCino
$75.71 /

+0.21 (+0.28%)

NCNO nCino
$75.71 /

+0.21 (+0.28%)

Hot Stocks
Townsquare expects Interactive business to generate $100M in two years » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
TSQ

Townsquare Media

$4.49 /

+0.08 (+1.81%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

04/14/20 Barrington
Townsquare Media downgraded to Market Perform at Barrington
04/14/20 Barrington
Townsquare Media downgraded to Market Perform from Outperform at Barrington
TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

Recommendations
Trump Administration likely to grant license to Qualcomm, says KeyBanc » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
QCOM

Qualcomm

$108.26 /

-2.72 (-2.45%)

, INTC

Intel

$48.04 /

-0.53 (-1.09%)

, MU

Micron

$48.75 /

+0.06 (+0.12%)

, XLNX

Xilinx

$107.40 /

-1.28 (-1.18%)

Following a recent Wall…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

INTC Intel
$48.04 /

-0.53 (-1.09%)

MU Micron
$48.75 /

+0.06 (+0.12%)

XLNX Xilinx
$107.40 /

-1.28 (-1.18%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

07:02 Today KeyBanc
Survey indicates strengthening recovery in Apple iPhone sales, says KeyBanc
08/03/20 Bernstein
Qualcomm upgraded to Outperform at Bernstein
08/03/20 Bernstein
Qualcomm upgraded to Outperform from Market Perform at Bernstein
07/31/20
Fly Intel: Top five analyst upgrades
INTC Intel
$48.04 /

-0.53 (-1.09%)

08/04/20 Jefferies
AMD price target raised to $95 from $86 at Jefferies
08/03/20 Roth Capital
MaxLinear price target raised to $35 from $30 at Roth Capital
08/03/20 Stifel
Stifel rises MaxLinear price target to $35 after completion of Home Gateway deal
07/31/20 Erste
Intel downgraded to Hold from Buy at Erste
MU Micron
$48.75 /

+0.06 (+0.12%)

07/28/20 Cleveland Research
Cleveland Research sees sharper pricing downside for DRAM and NAND
07/23/20 Raymond James
SK hynx's report generally consistent with Micron's, says Raymond James
06/30/20 RBC Capital
Micron price target raised to $60 from $55 at RBC Capital
06/30/20 Morgan Stanley
Morgan Stanley would add to Micron positions on weakness in coming 'rough patch'
XLNX Xilinx
$107.40 /

-1.28 (-1.18%)

07/31/20 Jefferies
Xilinx price target raised to $130 from $115 at Jefferies
07/31/20 BMO Capital
Xilinx price target raised to $110 from $90 at BMO Capital
07/31/20 Mizuho
Xilinx price target raised to $110 from $94 at Mizuho
07/17/20 Deutsche Bank
Xilinx price target raised to $100 from $90 at Deutsche Bank
QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

INTC Intel
$48.04 /

-0.53 (-1.09%)

MU Micron
$48.75 /

+0.06 (+0.12%)

XLNX Xilinx
$107.40 /

-1.28 (-1.18%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

INTC Intel
$48.04 /

-0.53 (-1.09%)

MU Micron
$48.75 /

+0.06 (+0.12%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

INTC Intel
$48.04 /

-0.53 (-1.09%)

MU Micron
$48.75 /

+0.06 (+0.12%)

XLNX Xilinx
$107.40 /

-1.28 (-1.18%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

INTC Intel
$48.04 /

-0.53 (-1.09%)

MU Micron
$48.75 /

+0.06 (+0.12%)

XLNX Xilinx
$107.40 /

-1.28 (-1.18%)

Hot Stocks
HUYA receives preliminary non-binding proposal from Tencent » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
HUYA

Huya

$26.65 /

-1.37 (-4.89%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, DOYU

DouYu

$15.23 /

-0.67 (-4.21%)

HUYA (HUYA) said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUYA Huya
$26.65 /

-1.37 (-4.89%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

DOYU DouYu
$15.23 /

-0.67 (-4.21%)

HUYA Huya
$26.65 /

-1.37 (-4.89%)

07/21/20 JPMorgan
Huya downgraded to Neutral from Overweight at JPMorgan
05/21/20 CLSA
Huya downgraded to Outperform from Buy at CLSA
05/21/20 Credit Suisse
Huya downgraded to Neutral on lack of catalysts at Credit Suisse
05/21/20 Credit Suisse
Huya downgraded to Neutral from Outperform at Credit Suisse
TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
DOYU DouYu
$15.23 /

-0.67 (-4.21%)

05/27/20 JPMorgan
DouYu upgraded to Overweight from Neutral at JPMorgan
12/05/19 Jefferies
DouYu initiated with a Buy at Jefferies
12/02/19 JPMorgan
DouYu downgraded to Neutral from Overweight at JPMorgan
12/02/19 Morgan Stanley
DouYu downgraded to Equal Weight from Overweight at Morgan Stanley
HUYA Huya
$26.65 /

-1.37 (-4.89%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

DOYU DouYu
$15.23 /

-0.67 (-4.21%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

HUYA Huya
$26.65 /

-1.37 (-4.89%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

HUYA Huya
$26.65 /

-1.37 (-4.89%)

Hot Stocks
Axsome Therapeutics completes enrollment in COMET Phase 3 study of AXS-05 » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Hot Stocks
Marriott CEO sees 'steady signs of demand returning' » 07:18
08/10/20
08/10
07:18
08/10/20
07:18
MAR

Marriott

$93.80 /

+3.41 (+3.77%)

Arne Sorenson, president…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

07/02/20 Citi
Marriott price target raised to $95 from $75 at Citi
06/25/20 Gordon Haskett
Marriott initiated with a Hold at Gordon Haskett
06/23/20 Nomura Instinet
Marriott price target raised to $148 from $123 at Nomura Instinet
06/22/20 Barclays
Barclays turns positive on lodging, upgrades Marriott to Overweight
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

Earnings
Townsquare Media reports Q2 adjusted EPS (40c), consensus (36c) » 07:16
08/10/20
08/10
07:16
08/10/20
07:16
TSQ

Townsquare Media

$4.49 /

+0.08 (+1.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

04/14/20 Barrington
Townsquare Media downgraded to Market Perform at Barrington
04/14/20 Barrington
Townsquare Media downgraded to Market Perform from Outperform at Barrington
TSQ Townsquare Media
$4.49 /

+0.08 (+1.81%)

Hot Stocks
Marriott added more than 11,400 rooms globally during Q2 » 07:16
08/10/20
08/10
07:16
08/10/20
07:16
MAR

Marriott

$93.80 /

+3.41 (+3.77%)

The company added more…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

07/02/20 Citi
Marriott price target raised to $95 from $75 at Citi
06/25/20 Gordon Haskett
Marriott initiated with a Hold at Gordon Haskett
06/23/20 Nomura Instinet
Marriott price target raised to $148 from $123 at Nomura Instinet
06/22/20 Barclays
Barclays turns positive on lodging, upgrades Marriott to Overweight
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

Syndicate
ViaSat files to sell 4.47M shares of common stock for holders  07:16
08/10/20
08/10
07:16
08/10/20
07:16
VSAT

ViaSat

$42.10 /

+3.48 (+9.01%)

 
ShowHide Related Items >><<
VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

05/27/20 JPMorgan
ViaSat price target lowered to $60 from $70 at JPMorgan
05/20/20 William Blair
ViaSat defense contract renewal positive for shares, says William Blair
04/20/20 Barclays
Barclays upgrades ViaSat to Equal Weight on more balanced risk/reward
04/20/20 Barclays
ViaSat upgraded to Equal Weight from Underweight at Barclays
VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

VSAT ViaSat
$42.10 /

+3.48 (+9.01%)

Hot Stocks
Morphic Holding to begin Phase 1 study of MORF-057 in Q3  07:16
08/10/20
08/10
07:16
08/10/20
07:16
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

 
ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb
Earnings
Pieris Pharmaceuticals reports Q2 EPS (9c), consensus (17c) » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
PIRS

Pieris Pharmaceuticals

$2.68 /

-0.06 (-2.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

Hot Stocks
NantKwest, CBR by Generate Life Sciences announce collaboration » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
NK

NantKwest

$10.54 /

+0.04 (+0.38%)

CBR by Generate Life…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NK NantKwest
$10.54 /

+0.04 (+0.38%)

NK NantKwest
$10.54 /

+0.04 (+0.38%)

07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Piper Sandler
NantKwest initiated with an Overweight at Piper Sandler
  • 25
    Jun
NK NantKwest
$10.54 /

+0.04 (+0.38%)

NK NantKwest
$10.54 /

+0.04 (+0.38%)

Hot Stocks
Morphic Holding expects cash to be sufficient through end of 2022 » 07:15
08/10/20
08/10
07:15
08/10/20
07:15
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb
Earnings
Morphic Holding reports Q2 EPS (52c), consensus (56c) » 07:14
08/10/20
08/10
07:14
08/10/20
07:14
MORF

Morphic Holding

$25.64 /

+1.24 (+5.08%)

Reports Q2 revenue $7.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MORF Morphic Holding
$25.64 /

+1.24 (+5.08%)

  • 12
    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.